#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombotic microangiopathy Anal cancer Immune-mediated renal disorder Cystic fibrosis Pulmonary sarcoidosis Hereditary angioedema Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Pancreatic carcinoma Hereditary haemorrhagic telangiectasia Pseudoxanthoma elasticum Breast cancer metastatic Oesophageal squamous cell carcinoma stage II Uveitis Squamous cell carcinoma of the vulva Craniocerebral injury More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma – Basic Information Aicardi-Goutieres syndrome – Treatment Hereditary motor and sensory neuropathy – Trials in Disease Angelman’s syndrome – Basic Information Glomerulonephritis membranous – Life with Disease Pemphigus – Diagnostics Mantle cell lymphoma stage II – Trials in Disease Mantle cell lymphoma stage IV Haemophilia B with anti factor IX – Basic Information Lennox-Gastaut syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Reboxetine Valemetostat Tosilate Brivaracetam MARALIXIBAT Escitalopram Oxalate Bi 1291583 Posdinemab Betamethasone Acetate Lbl-007 LUMC-BOB1-B7-TCR.1 Palonosetron Flucloxacillin Olaptesed Pegol Leriglitazone AZD0022 Thymalfasin Sparsentan Methylphenidate Hydrochloride Zidovudine Cpft Trifluoroacetate More therapies…

    Learn about Your Condition

    Agitation postoperative Anorexia nervosa Cystic fibrosis lung Malignant fibrous histiocytoma Delirium Mantle cell lymphoma stage IV Menopausal symptoms Bladder cancer recurrent Haemoptysis Systemic mastocytosis Osteogenesis imperfecta Respiratory tract infection Thalassaemia alpha Primary hypogonadism Macular degeneration More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. CHU Croix Rousse-Lyon

CHU Croix Rousse-Lyon

103 Grande Rue De La Croix Rousse, Lyon, 69317, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Tepotinib to Standard Treatment for Patients with Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Tepotinib
    • Atezolizumab
    • Bevacizumab
    France

  • Study of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Tezepelumab
    Belgium Bulgaria Denmark France Greece Hungary +3

  • Study on Tozorakimab for Adults with Uncontrolled Asthma Using Medium-to-High Dose Inhaled Corticosteroids

    Recruiting

    2 1 1
    Investigated Drugs:
    • Tozorakimab
    • Salbutamol Sulfate
    France Greece Hungary Italy Spain

  • Study on the Effectiveness and Safety of GAL-101 Eye Drops for Patients with Geographic Atrophy from Age-Related Macular Degeneration

    Recruiting

    2 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • SODIUM (R)-2-(2-AMINO-3-(1H-INDOL-3- YL)PROPANAMIDO)-2-METHYLPROPANOATE-PROPAN-2-OL
    France Germany Ireland Italy

  • Study on Stopping Dupilumab in Patients with Severe Asthma Who Have Been on the Drug for Over 3 Years

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Dupilumab
    France

  • Study on the Safety and Immune Response of the 20-Valent Pneumococcal Vaccine in Adults with Fever and High Risk for Pneumococcal Infection

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197
    • Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197
    • Pneumococcal Polysaccharide Serotype 12F Conjugated To Crm197
    France

  • Study of Pozelimab and Cemdisiran for Adults with Geographic Atrophy from Age-Related Macular Degeneration

    Recruiting

    3 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    • Age-related macular degeneration
    Investigated Drugs:
    • Cemdisiran
    • Pozelimab
    Austria France Germany Hungary Italy Poland +1

  • Study on the Safety of Atezolizumab and Bevacizumab for Liver Transplant Patients with Advanced Liver Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Liver transplant
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    France

  • Study on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis

    Recruiting

    3 1
    Investigated Diseases:
    • Metabolic dysfunction-associated liver disease
    Investigated Drugs:
    • Bio89-100
    Austria Belgium Bulgaria Czechia France Germany +4

  • Study on Long-Term Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a Port Delivery System

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Ranibizumab
    Austria Belgium France Germany Italy Spain
Previous Page
1 2 3 4 … 12
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!